EIF1AX and poorly differentiated thyroid gland carcinoma: EIF1AX mutations were initially discovered in uveal melanomas7 and reported in 11% of poorly differentiated thyroid cancers (PDTCs) and anaplastic thyroid cancers (ATCs), and almost invariably associated with oncogenic RAS mutations.11, 17